AYLA logo

Ayala Pharmaceuticals (AYLA) EBITDA

AYLA Annual EBITDA

-$39.05 M
-$9.46 M-31.95%

31 December 2021

AYLA EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AYLA Quarterly EBITDA

-$10.04 M
-$2.25 M-28.91%

30 September 2022

AYLA Quarterly EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AYLA TTM EBITDA

-$37.39 M
-$521.00 K-1.41%

30 September 2022

AYLA TTM EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AYLA EBITDA Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-31.9%-5.5%+3.2%
3 y3 years-334.6%-103.3%-112.9%
5 y5 years-334.6%-180.5%-112.9%

AYLA EBITDA High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time+334.6%+180.5%+944.5%

Ayala Pharmaceuticals EBITDA History

DateAnnualQuarterlyTTM
Sept 2022
-
-$10.04 M(+28.9%)
-$37.39 M(+1.4%)
June 2022
-
-$7.79 M(-20.7%)
-$36.87 M(-7.2%)
Mar 2022
-
-$9.82 M(+0.9%)
-$39.74 M(+1.9%)
Dec 2021
-$39.05 M(+31.9%)
-$9.74 M(+2.3%)
-$38.98 M(+0.9%)
Sept 2021
-
-$9.52 M(-10.7%)
-$38.64 M(+6.3%)
June 2021
-
-$10.66 M(+17.6%)
-$36.35 M(+12.6%)
Mar 2021
-
-$9.06 M(-3.6%)
-$32.27 M(+9.0%)
Dec 2020
-$29.59 M
-$9.40 M(+29.9%)
-$29.59 M(+16.1%)
DateAnnualQuarterlyTTM
Sept 2020
-
-$7.23 M(+10.0%)
-$25.48 M(+9.9%)
June 2020
-
-$6.58 M(+3.0%)
-$23.18 M(+13.8%)
Mar 2020
-
-$6.39 M(+20.9%)
-$20.37 M(+16.0%)
Dec 2019
-$17.56 M(+95.4%)
-$5.28 M(+7.0%)
-$17.56 M(+43.0%)
Sept 2019
-
-$4.94 M(+31.3%)
-$12.28 M(+67.3%)
June 2019
-
-$3.76 M(+5.0%)
-$7.34 M(+105.0%)
Mar 2019
-
-$3.58 M
-$3.58 M
Dec 2018
-$8.99 M
-
-

FAQ

  • What is Ayala Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
  • What is the all time high annual EBITDA for Ayala Pharmaceuticals?
  • What is Ayala Pharmaceuticals annual EBITDA year-on-year change?
  • What is Ayala Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
  • What is the all time high quarterly EBITDA for Ayala Pharmaceuticals?
  • What is Ayala Pharmaceuticals quarterly EBITDA year-on-year change?
  • What is Ayala Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
  • What is the all time high TTM EBITDA for Ayala Pharmaceuticals?
  • What is Ayala Pharmaceuticals TTM EBITDA year-on-year change?

What is Ayala Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?

The current annual EBITDA of AYLA is -$39.05 M

What is the all time high annual EBITDA for Ayala Pharmaceuticals?

Ayala Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is -$8.99 M

What is Ayala Pharmaceuticals annual EBITDA year-on-year change?

Over the past year, AYLA annual earnings before interest, taxes, depreciation & amortization has changed by -$9.46 M (-31.95%)

What is Ayala Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?

The current quarterly EBITDA of AYLA is -$10.04 M

What is the all time high quarterly EBITDA for Ayala Pharmaceuticals?

Ayala Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$3.58 M

What is Ayala Pharmaceuticals quarterly EBITDA year-on-year change?

Over the past year, AYLA quarterly earnings before interest, taxes, depreciation & amortization has changed by -$521.00 K (-5.47%)

What is Ayala Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?

The current TTM EBITDA of AYLA is -$37.39 M

What is the all time high TTM EBITDA for Ayala Pharmaceuticals?

Ayala Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is -$3.58 M

What is Ayala Pharmaceuticals TTM EBITDA year-on-year change?

Over the past year, AYLA TTM earnings before interest, taxes, depreciation & amortization has changed by +$1.25 M (+3.22%)